standard]
MDGTIQDGSSVDSFLRNYKLGKTLGIGSFGKVKIAEHALTGHKVAVKILN
RKKIKNMDMEEKGRSSAYAINVHITIFRREIKILRLFMHPHIIRLYEVVE
THSDIYVVMEYVKSGELFDYIVEKGRLHEEEARMFFQQIISGVEYCHRNM
VVHRDLKPENLLLDSKHNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV
ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP
SHLSAGARDLIPRMLIVDPMKRMTIPEIRAHPWFQAHLPRYLAVPPPDTT
QQAKKIDEDILQEVIKMGFDRTALVDSLRNRVQNEGTVTYYLLLDNRFRV
SNGYLGAEFQETMEFGYNRNMSETVASPVGQRFPGVIDYQQFGGRQFPAD
RKWALGLQSRAHPREIMTEVLKALQELNVSWKKIGQYNMKCRWAPCSPSH
HEGMLNNSMHDNNYFGDESAIIENDGNVRPQNVVKFEVQLYKTREDKYLL
DLQRVQGPQFLFLDLCAAFLAQLRVL
|
IPR000449; Ubiquitin-associated/translation elongation factor EF1B, N-terminal IPR000719; Protein kinase, catalytic domain IPR001772; Kinase-associated KA1 IPR002290; Serine/threonine-protein kinase d |